{"name":"Axcynsis Therapeutics Pte Ltd","slug":"axcynsis-therapeutics-pte-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AT03-65","genericName":"AT03-65","slug":"at03-65","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AT03-65","genericName":"AT03-65","slug":"at03-65","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOeVhPLXo0S3hKcURBQnZIbmY4VENQX3FuX1NPYURMNWZXS1p0Y3VrN0YyejdPOVk2YkdVRWZWeVhscWFia1JGRWEta1pBQnRUaTJOam02cWIyMkxxdlpfRUpkeElKRzlSZGNON2twUENpTVFFNEFHNGJ5MTExUGFoMUZpczdDR20ydzBpYW1TTTE3cjBrdDQ0eXVSM1daOGVnOXIyRXBUOUhNbFRTbXV4NVlxckNvanZYbGxQVzdVa2lmMkhvN1VHWVhwLXZxQmppUnplYTJ3?oc=5","date":"2025-01-15","type":"regulatory","source":"BioPharma APAC","summary":"Axcynsis Therapeutics Secures FDA Clearance for First ADC Program Utilizing AxcynDOT™ Technology - BioPharma APAC","headline":"Axcynsis Therapeutics Secures FDA Clearance for First ADC Program Utilizing AxcynDOT™ Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOREh1akEtWUIzV0lPN0pMZFRab2liY081ZVdRNGdHdWExa2Q0ZnFWZklaRnBKbXdFQUJkZUFRT3Vha2tVYW5VY2t1MlN3U19fWl9ONUpwR1h2NlRENm01OUc2RFhuT0xIa0tBWFpNWlU5SFFPdkhqSzBMSFJ6RzNWOUJfc1pfeEc0SHMtN2hXbk80a2Z4OGw4TnJhUVppYnl2MGQ0TFlR?oc=5","date":"2024-09-27","type":"patent","source":"BioWorld News","summary":"Axcynsis Therapeutics patents new ADCs for treatment of cancer - BioWorld News","headline":"Axcynsis Therapeutics patents new ADCs for treatment of cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPeFY0OUZwUGE2VkF0UlRZNG51Y08zMVBNWHpYRHBNUTJPZGVTWWtGdFlad3RzcFJIaFp6T21JY0lsc04yNVY5cEFKMmxHOFJzRmtaem1hbGpPc2JNTWVsWVBWR0dvc19QNTFYVnp1bzJ1TXVXSUJuTU80bkN2ZTJvT0lSeHZObFlOczB6dVhIa3o1MlhkMU1NaFBtYzhpdloyS0E0d3JrZHN5RVBUeDVvRGUzOF9uZWNS?oc=5","date":"2024-08-20","type":"pipeline","source":"BioWorld News","summary":"Chengdu Duote Antibody Pharmaceutical discovers new antibody-drug conjugates - BioWorld News","headline":"Chengdu Duote Antibody Pharmaceutical discovers new antibody-drug conjugates","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}